المؤلفون: Woyach, J., Flinn, I. W., Awan, F. T., Eradat, H., Brander, D., Tees, M., Parikh, S. A., Phillips, T., Wang, W., Reddy, N. M., Farooqui, M. Z., Byrd, J. C., Stephens, D. M.

المصدر: HemaSphere ; volume 6, page 578-579 ; ISSN 2572-9241

الإتاحة: https://doi.org/10.1097/01.hs9.0000845612.25766.0cTest

المؤلفون: Kim Y. H., Prince H. M., Whittaker S., Horwitz S. M., Duvic M., Bechter O., Sanches J. A., Stadler R., Scarisbrick J., Quaglino P., Zinzani P. L., Wolter P., Eradat H., Pinter-Brown L. C., Ortiz-Romero P. L., Akilov O. E., Trotman J., Taylor K., Weichenthal M., Walewski J., Fisher D., McNeeley M., Gru A. A., Brown L., Palanca-Wessels M. C., Lisano J., Onsum M., Bunn V., Little M., Trepicchio W. L., Dummer R.

المساهمون: Kim Y.H., Prince H.M., Whittaker S., Horwitz S.M., Duvic M., Bechter O., Sanches J.A., Stadler R., Scarisbrick J., Quaglino P., Zinzani P.L., Wolter P., Eradat H., Pinter-Brown L.C., Ortiz-Romero P.L., Akilov O.E., Trotman J., Taylor K., Weichenthal M., Walewski J., Fisher D., McNeeley M., Gru A.A., Brown L., Palanca-Wessels M.C., Lisano J., Onsum M., Bunn V., Little M., Trepicchio W.L., Dummer R.

مصطلحات موضوعية: Antibody-drug conjugate, Brentuximab vedotin, CD30, Cutaneous T-cell lymphoma, Efficacy, Large-cell transformation, Mycosis fungoide, Objective response, Progression-free survival, Safety, Adult, Aged, 80 and over, Antineoplastic Agents, Immunological, Female, Follow-Up Studie, Human, International Agencie, Ki-1 Antigen, Male, Middle Aged, Physician, Prognosi, Retrospective Studie, Survival Rate, Young Adult, Choice Behavior, Decision Support Techniques

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33794441; info:eu-repo/semantics/altIdentifier/wos/WOS:000644993500008; volume:148; firstpage:411; lastpage:421; numberofpages:11; journal:EUROPEAN JOURNAL OF CANCER; https://hdl.handle.net/11585/866724Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85103377885; https://linkinghub.elsevier.com/retrieve/pii/S0959804921001180Test

الإتاحة: https://doi.org/10.1016/j.ejca.2021.01.054Test
https://hdl.handle.net/11585/866724Test
https://linkinghub.elsevier.com/retrieve/pii/S0959804921001180Test

المؤلفون: Horwitz S. M., Scarisbrick J. J., Dummer R., Whittaker S., Duvic M., Kim Y. H., Quaglino P., Zinzani P. L., Bechter O., Eradat H., Pinter-Brown L., Akilov O. E., Geskin L., Sanches J. A., Ortiz-Romero P. L., Weichenthal M., Fisher D. C., Walewski J., Trotman J., Taylor K., Dalle S., Stadler R., Lisano J., Bunn V., Little M., Miles Prince H.

المساهمون: Horwitz S.M., Scarisbrick J.J., Dummer R., Whittaker S., Duvic M., Kim Y.H., Quaglino P., Zinzani P.L., Bechter O., Eradat H., Pinter-Brown L., Akilov O.E., Geskin L., Sanches J.A., Ortiz-Romero P.L., Weichenthal M., Fisher D.C., Walewski J., Trotman J., Taylor K., Dalle S., Stadler R., Lisano J., Bunn V., Little M., Miles Prince H.

مصطلحات موضوعية: Adult, Brentuximab Vedotin, Human, Quality of Life, Lymphoma, T-Cell, Cutaneou, Physician, Skin Neoplasms

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34507350; info:eu-repo/semantics/altIdentifier/wos/WOS:000733368000011; volume:5; issue:23; firstpage:5098; lastpage:5106; numberofpages:9; journal:BLOOD ADVANCES; https://hdl.handle.net/11585/867056Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85121718931; https://ashpublications.org/bloodadvances/article/5/23/5098/476861/Randomized-phase-3-ALCANZA-study-of-brentuximabTest

الإتاحة: https://doi.org/10.1182/bloodadvances.2021004710Test
https://hdl.handle.net/11585/867056Test
https://ashpublications.org/bloodadvances/article/5/23/5098/476861/Randomized-phase-3-ALCANZA-study-of-brentuximabTest

المؤلفون: Dummer R., Prince H. M., Whittaker S., Horwitz S. M., Kim Y. H., Scarisbrick J., Quaglino P., Zinzani P. L., Wolter P., Eradat H., Pinter-Brown L., Sanches J. A., Ortiz-Romero P. L., Akilov O. E., Geskin L., Huen A., Walewski J., Wang Y., Lisano J., Richhariya A., Feliciano J., Zhu Y., Bunn V., Little M., Zagadailov E., Dalal M. R., Duvic M.

المساهمون: Dummer R., Prince H.M., Whittaker S., Horwitz S.M., Kim Y.H., Scarisbrick J., Quaglino P., Zinzani P.L., Wolter P., Eradat H., Pinter-Brown L., Sanches J.A., Ortiz-Romero P.L., Akilov O.E., Geskin L., Huen A., Walewski J., Wang Y., Lisano J., Richhariya A., Feliciano J., Zhu Y., Bunn V., Little M., Zagadailov E., Dalal M.R., Duvic M.

مصطلحات موضوعية: Brentuximab vedotin, CD30, Clinical trial, Cutaneous T-cell lymphoma, Phase III, Quality of life

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000540721200016; volume:133; firstpage:120; lastpage:130; numberofpages:11; journal:EUROPEAN JOURNAL OF CANCER; https://hdl.handle.net/11585/805881Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85085573690; https://www.sciencedirect.com/science/article/pii/S0959804920302082Test

الإتاحة: https://doi.org/10.1016/j.ejca.2020.04.010Test
https://hdl.handle.net/11585/805881Test
https://www.sciencedirect.com/science/article/pii/S0959804920302082Test

المؤلفون: Kim, YH, Prince, HM, Whittaker, S, Horwitz, SM, Duvic, M, Bechter, O, Sanches, JA, Stadler, R, Scarisbrick, J, Quaglino, P, Zinzani, PL, Wolter, P, Eradat, H, Pinter-Brown, LC, Ortiz-Romero, PL, Akilov, OE, Trotman, J, Taylor, K, Weichenthal, M, Walewski, J, Fisher, D, McNeeley, M, Gru, AA, Brown, L, Palanca-Wessels, MC, Lisano, J, Onsum, M, Bunn, V, Little, M, Trepicchio, WL, Dummer, R

العلاقة: pii: S0959-8049(21)00118-0; Kim, Y. H., Prince, H. M., Whittaker, S., Horwitz, S. M., Duvic, M., Bechter, O., Sanches, J. A., Stadler, R., Scarisbrick, J., Quaglino, P., Zinzani, P. L., Wolter, P., Eradat, H., Pinter-Brown, L. C., Ortiz-Romero, P. L., Akilov, O. E., Trotman, J., Taylor, K., Weichenthal, M. ,. Dummer, R. (2021). Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis. EUROPEAN JOURNAL OF CANCER, 148, pp.411-421. https://doi.org/10.1016/j.ejca.2021.01.054Test.; http://hdl.handle.net/11343/281679Test

الإتاحة: https://doi.org/10.1016/j.ejca.2021.01.054Test
http://hdl.handle.net/11343/281679Test

المؤلفون: Horwitz, SM, Scarisbrick, JJ, Dummer, R, Whittaker, S, Duvic, M, Kim, YH, Quaglino, P, Zinzani, PL, Bechter, O, Eradat, H, Pinter-Brown, L, Akilov, OE, Geskin, L, Sanches, JA, Ortiz-Romero, PL, Weichenthal, M, Fisher, DC, Walewski, J, Trotman, J, Taylor, K, Dalle, S, Stadler, R, Lisano, J, Bunn, V, Little, M, Prince, HM

العلاقة: pii: 476861; Horwitz, S. M., Scarisbrick, J. J., Dummer, R., Whittaker, S., Duvic, M., Kim, Y. H., Quaglino, P., Zinzani, P. L., Bechter, O., Eradat, H., Pinter-Brown, L., Akilov, O. E., Geskin, L., Sanches, J. A., Ortiz-Romero, P. L., Weichenthal, M., Fisher, D. C., Walewski, J., Trotman, J. ,. Prince, H. M. (2021). Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data. BLOOD ADVANCES, 5 (23), pp.5098-5106. https://doi.org/10.1182/bloodadvances.2021004710Test.; http://hdl.handle.net/11343/301623Test

الإتاحة: https://doi.org/10.1182/bloodadvances.2021004710Test
http://hdl.handle.net/11343/301623Test

المؤلفون: Olszewski, A. J, Avigdor, A, Babu, S, Levi, I, Eradat, H, Abadi, U, Holmes, H, McKinney, M, Woszczyk, D, Giannopoulos, K, Jurczak, W, McCord, R, Xie, Y, Sarouei, K, Qayum, N, O'Hear, C, Sellam, G, Horowitz, N

المصدر: Hematological Oncology ; volume 39, issue S2 ; ISSN 0278-0232 1099-1069

الإتاحة: https://doi.org/10.1002/hon.152_2880Test

المؤلفون: Eradat, H., Woyach, J., Flinn, I. W., Awan, F. T., Brander, D., Tees, M., Parikh, S. A., Phillips, T., Ghori, R., Paydar, I., Farooqui, M. Z. H., Byrd, J. C., Stephens, D. M.

المصدر: Hematological Oncology ; volume 41, issue S2, page 565-567 ; ISSN 0278-0232 1099-1069

الإتاحة: https://doi.org/10.1002/hon.3164_423Test

المؤلفون: Mozas, P., Ammar, R. Ould, Chartier, L., Nastoupil, L., Bachy, E., Bezsera, S. M., Barnes, J., Bijou, F., Goy, A., Zerazhi, H., Cartron, G., Ojeda‐Uribe, M., Choquet, S., Joly, B., Cheminant, M., García‐Sancho, A. Martín, Eradat, H., Gressin, R., Abrisqueta, P., Parcelier, A., Salazar, M. J. Rodríguez, Bonnet, C., Crump, M., López‐Guillermo, A., Morschhauser, F.

المصدر: Hematological Oncology ; volume 41, issue S2, page 290-291 ; ISSN 0278-0232 1099-1069

الإتاحة: https://doi.org/10.1002/hon.3164_200Test

المؤلفون: Locke, F. L., Lekakis, L., Eradat, H., Munoz, J., Tees, M., de Vos, S., Nath, R., Stevens, D., Malik, S., Popplewell, L., Hamadani, M., Oluwole, O., Perales, M., Miklos, D., Fisher, P., Goyal, L., Navale, L., Kaufman, G., Kai, K., Balakumaran, A., Neelapu, S.

المصدر: Hematological Oncology ; volume 41, issue S2, page 85-86 ; ISSN 0278-0232 1099-1069

الإتاحة: https://doi.org/10.1002/hon.3163_48Test